Smoking Outcomes Worse for Minority Adults Versus White Adults
By Lori Solomon HealthDay Reporter
THURSDAY, Dec. 7, 2023 -- Minority populations will benefit much more than the U.S. White adult population from antitobacco regulations that reduce smoking, according to a study published online Dec. 5 in Tobacco Control.
R. Burciaga Valdez, Ph.D., from the Agency for Healthcare Research and Quality in Rockville, Maryland, and William Encinosa, Ph.D., from the Georgetown University McCourt School of Public Policy in Washington, D.C., used linked data from the Medical Expenditure Panel Survey (2008 to 2019) and the National Health Interview Survey to estimate racial and ethnic disparities in spending and outcomes associated with smoking.
The researchers found that White adults had higher ever-smoked rates, but minority smoking adults had twice as much of their annual medical spending associated with smoking than White smoking adults (25 versus 12 percent). Compared with White adults, minority adults who smoked had 41 percent higher risks for multiple chronic conditions associated with smoking. The desire to quit declined among White adults (53 percent in 2019) but increased for minorities (63 percent). Smoking comprised 7.5 percent of the nation's spending for White adults from 2008 to 2016, and 10.7 percent for minorities, with further declines for 2017 to 2019 (2.5 and 8.9 percent, respectively). The cost savings resulting from any new antitobacco regulation would be $134 million per year for every 100,000 minorities averted from initiating smoking versus $57 million saved annually for 100,000 White adults averted.
"Minority adults may benefit substantially more from antitobacco regulations and past federal cost-benefit analyses would have overlooked this," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted December 2023
Read this next
Cytisinicline Beneficial for Cessation of Electronic Cigarette Smoking
MONDAY, May 13, 2024 -- Cytisinicline for 12 weeks with behavioral support is efficacious for cessation of electronic cigarette smoking, according to a study published online May...
Upping Dose May Aid Smoking Cessation After Initial Treatment Failure
TUESDAY, May 7, 2024 -- A dosage increase may provide longer-term benefit for smokers receiving varenicline or combination nicotine replacement therapy who are nonabstinent after...
Quantitative Interstitial Abnormality Linked to Severe ARD in Smokers
MONDAY, May 6, 2024 -- For individuals with a smoking history, quantitative interstitial abnormality (QIA) progression is associated with increased odds of severe acute...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.